Market openNon-fractional

Hikma Pharmaceuticals/HIK

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX

About Hikma Pharmaceuticals

Ticker

HIK

Sector

Healthcare

Trading on

LSE

Industry

Pharmaceuticals

Headquarters

London, United Kingdom

Employees

9,100

HIK Metrics

BasicAdvanced
£4.1B
Market cap
27.54
P/E ratio
£0.67
EPS
0.45
Beta
£0.57
Dividend rate
3.08%
Dividend yield
£4.1B
0.45
£0.57
1.568
0.805
46.627
53.916
72.11%
5.96%
7.32%
8.81%
27.54
1.8
1.85
3.71
12.8
3.08%
14.22%
1.67%
7.09%
-22.29%
12.92%

What the Analysts think about HIK

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Hikma Pharmaceuticals stock.

HIK Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

HIK Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Hikma Pharmaceuticals stock?

Hikma Pharmaceuticals (HIK) has a market cap of £4.1B as of July 04, 2024.

What is the P/E ratio for Hikma Pharmaceuticals stock?

The price to earnings (P/E) ratio for Hikma Pharmaceuticals (HIK) stock is 27.54 as of July 04, 2024.

Does Hikma Pharmaceuticals stock pay dividends?

Yes, the Hikma Pharmaceuticals (HIK) stock pays dividends to shareholders. As of July 04, 2024, the dividend rate is £0.56748 and the yield is 3.08%. Hikma Pharmaceuticals has a payout ratio of 72.11% on a trailing twelve-month basis.

When is the next Hikma Pharmaceuticals dividend payment date?

The next Hikma Pharmaceuticals (HIK) dividend payment date is unconfirmed.

What is the beta indicator for Hikma Pharmaceuticals?

Hikma Pharmaceuticals (HIK) has a beta rating of 0.45. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Hikma Pharmaceuticals stock

Buy or sell Hikma Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing